Breakthrough of the Year (almost!)

As the year draws to a close it’s time to reflect on an exciting year of animal research, and there seems no better place to start than with the top 10 breakthroughs of the year as selected by the prestigious scientific journal Science. Science is of course a general science magazine, and the choices reflect … Continue reading Breakthrough of the Year (almost!)

Gene therapy for blindness – when dogged determination pays off!

Leber's congenital amaurosis is a progressive disorder that affects about 3,000 Americans, and hundreds of thousands worldwide, and causes a progressive loss of vision that usually results in blindness. The disease, for which there has until now been no effective treatment, is caused by a mutation in the encoding RPE65, an enzyme which is crucial … Continue reading Gene therapy for blindness – when dogged determination pays off!

Positive Comments for Pro-Test Petition!!

The Pro-Test Petition has now reached well over 2700 signatures - have you signed yet? This petition, supported by  Speaking of Research, Americans for Medical Progress, and UCLA Pro-Test,  aims to show the world that the majority do support animal research – and moreover they dare stand up and sign their name to it. On … Continue reading Positive Comments for Pro-Test Petition!!

Stem cell hope for Duchenne muscular dystrophy

Duchenne muscular dystrophy (DMD) is an inherited disease that affects about one in every 4,000 males born in the USA. It is caused by mutations in the DMD gene that lead to the protein dystrophin being either absent or faulty, which leads to muscle cell death, progressive muscle wasting and early death, with few patients … Continue reading Stem cell hope for Duchenne muscular dystrophy

Animal research behind the headlines

The BBC has reported on calls for the new blood-thinning drug Pradaxa (dabigatran etexilate/BIBR 1048) to be used more widely in patients who are at risk of blood clots following surgery, a serious complication that kills 25,000 patients each year. This drug works be inhibiting the enzyme Thrombin, a key player in clot formation. reading Animal research behind the headlines